SCHEMBL24907425

SCHEMBL24907425

CCn1cc(N=O)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13494687 0.76 L3MBTL1 (0.33)
SCHEMBL18156042 0.75 ACHE (0.38)
SCHEMBL1783370 0.75 P2RY6 (0.38)
SCHEMBL24908210 0.75 LRRK2 (0.33)
SCHEMBL15580562 0.72 L3MBTL1 (0.57)
SCHEMBL17459858 0.71
SCHEMBL3683850 0.71
SCHEMBL28183880 0.70 SCD (0.33)
SCHEMBL293672 0.69
SCHEMBL3686568 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303540-A1 2-AMINOQUINAZOLINES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME LLC (US) 2023-09-28 US disclosed
US-20230023066-A1 N-(HETEROARYL) QUINAZOLIN-2-AMINE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME CORP. (US) 2023-01-26 US disclosed